시장보고서
상품코드
1951654

피임약 시장 보고서(2026년)

Contraceptives Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

피임약 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 297억 4,000만 달러에서 2026년에는 320억 2,000만 달러로, CAGR 7.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 정부 주도의 가족계획 정책, 경구피임약의 접근성 향상, 도시 지역 여성의 노동력 참여율 증가, 인구 억제에 대한 공중보건 캠페인, 병원 및 클리닉의 피임 서비스 확대 등이 주요 요인으로 꼽힙니다.

피임약 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 430억 9,000만 달러에 달하며, CAGR은 7.7%에 달할 전망입니다. 예측 기간 중 비호르몬 및 남성 피임법의 혁신, 온라인 약국 보급 확대, 청소년의 생식 건강에 대한 인식 증가, 이식형 장치의 기술 발전, 새로운 피임법에 대한 규제 당국의 승인 지원 등이 성장 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 장기 지속형 가역적 피임법(LARC) 채택 증가, 비호르몬 피임법 선호도 증가, 여성 주도형 피임법 수요 증가, 시판약 및 자가투여 제품 확대, 청소년 및 청년층 피임 인식 제고에 대한 노력 강화 등을 꼽을 수 있습니다.

세계 인구 증가는 향후 수년간 피임 시장 성장을 촉진할 것으로 예측됩니다. 인구란 특정 지역, 국가 또는 전 세계에 거주하는 개인의 총 수를 의미합니다. 피임법은 개인과 부부가 가족계획을 세우고, 가구 규모를 관리하고, 출산 간격을 조절할 수 있게 함으로써 인구 억제에 중요한 역할을 합니다. 예를 들어 2024년 12월 미국 연방정부 기관인 미국 인구조사국이 발표한 자료에 따르면 2024년 7월 1일 기준 미국 인구는 3억 4,010만 명으로 2023년 3억 3,680만 명에서 0.98% 증가했습니다. 이는 역대 최고 연간 성장률을 기록한 것입니다. 이처럼 세계 인구 증가율이 피임약 시장의 성장을 가속하고 있습니다.

피임약 시장에서 사업을 운영하는 주요 기업은 기존 소비자의 요구를 더 잘 충족시키기 위해 프로게스틴 단독 경구 피임약 '오필'과 같은 혁신적인 제품 개발에 주력하고 있습니다. 오필은 프로게스틴 단독 경구피임약(일명 미니 피임약)으로, 합성 프로게스테론인 프로게스틴만을 함유한 피임약의 일종입니다. 예를 들어 2023년 7월 아일랜드에 본사를 둔 시판 의약품 제조업체인 페리고 컴퍼니(Perigo Company)는 미국 식품의약국(FDA)이 오필(progestin-only oral contraceptive)을 승인했다고 발표했습니다. 오필은 미국에서 최초로 처방전 없이 구입할 수 있는 피임약이 되어 여성들의 피임 접근성을 크게 향상시킴과 동시에, 삶의 질을 향상시키는 효과적인 솔루션을 지속적으로 제공하겠다는 페리고의 의지를 보여주었습니다.

자주 묻는 질문

  • 피임약 시장 규모는 어떻게 변화하고 있나요?
  • 피임약 시장의 성장 요인은 무엇인가요?
  • 피임약 시장에서의 주요 기업은 어떤 혁신을 추구하고 있나요?
  • 세계 인구 증가는 피임약 시장에 어떤 영향을 미치고 있나요?
  • 피임약 시장의 주요 동향은 무엇인가요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.03.26

Contraceptives refer to methods or practices that involve the use of various medicines, sexual behaviors, chemicals, medications, or surgical procedures to deliberately prevent conception. A contraceptive is any method, measure, or action intended to prevent a woman from becoming pregnant.

The primary product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intrauterine devices. Oral contraceptive pills, also known as birth control pills, are tablets taken to prevent pregnancy and contain hormones that inhibit the release of eggs from the ovaries. Contraceptives are used by a broad range of age groups, including individuals aged 15-24 years, 25-34 years, 35-44 years, and over 44 years. These products are distributed through clinics, hospitals, independent pharmacies, and other outlets.

Tariffs have impacted the contraceptives market by increasing the cost of imported active pharmaceutical ingredients, medical-grade polymers, and device components used in pills, condoms, implants, and IUDs. This has affected pricing and supply stability across oral contraceptives, intra-uterine devices, and subdermal implants, with Asia-Pacific and Latin America being most impacted due to reliance on cross-border manufacturing. However, tariffs have also encouraged regional manufacturing, local sourcing, and strategic partnerships, supporting supply chain resilience and long-term domestic production growth.

The contraceptives market research report is one of a series of new reports from The Business Research Company that provides contraceptives market statistics, including contraceptives industry global market size, regional shares, competitors with a contraceptives market share, detailed contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. This contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contraceptives market size has grown strongly in recent years. It will grow from $29.74 billion in 2025 to $32.02 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government-led family planning initiatives, increased availability of oral contraceptive pills, rising urban female workforce participation, public health campaigns on population control, expansion of hospital and clinic-based contraceptive services.

The contraceptives market size is expected to see strong growth in the next few years. It will grow to $43.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growth in non-hormonal and male contraceptive innovation, rising penetration of online pharmacies, increasing reproductive health awareness among adolescents, technological advancements in implantable devices, supportive regulatory approvals for novel contraceptives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing preference for non-hormonal contraceptive options, growing demand for female-controlled contraceptive methods, expansion of over-the-counter and self-administered products, increasing focus on adolescent and young adult contraceptive awareness.

The global increase in population levels is anticipated to drive the growth of the contraceptive market in the coming years. Population refers to the total number of individuals or people living within a specific geographic area, country, or across the world. Contraceptives play an important role in population control by enabling individuals and couples to plan families, manage household size, and space childbirth. For example, in December 2024, the United States Census Bureau, a US-based federal agency, reported that the US population reached 340.1 million as of July 1, 2024, representing a 0.98% increase from 336.8 million in 2023-the highest annual growth rate recorded. Consequently, the global rise in population rates is fueling the growth of the contraceptive market.

Leading companies operating in the contraceptives market are concentrating on the development of innovative products, such as Opill, a progestin-only daily oral contraceptive, to better address the needs of existing consumers. Opill progestin-only daily oral contraceptives, commonly referred to as the mini-pill, are a type of birth control pill that contains only progestin, a synthetic form of the hormone progesterone. For example, in July 2023, Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, announced that the US Food and Drug Administration (FDA) had approved Opill progestin-only daily oral contraceptives. Opill became the first birth control pill available without a prescription in the United States, significantly improving access to contraceptives for women and demonstrating Perrigo's ongoing commitment to delivering impactful solutions that enhance quality of life.

In March 2024, Insud Pharma, a Spain-based pharmaceutical manufacturing company, acquired oral and injectable contraceptive products from Viatris for an undisclosed amount. Through this acquisition, Insud Pharma seeks to strengthen its women's health portfolio by incorporating Viatris' oral and injectable contraceptives, thereby expanding its market presence and offering a wider range of reproductive healthcare solutions to address the growing demand for contraceptive options. Viatris is a US-based pharmaceutical manufacturing company.

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Oral Contraceptive Pills; Topical Contraceptives; Injectables; Diaphragms; Vaginal Rings; Condoms; Contraceptive Sponges; Subdermal Implants; Intra-Uterine Devices
  • 2) By Age Group: 15-24 Years; 25-34 Years; 35-44 Years; 44 Years
  • 3) By Distribution Channel: Hospital Pharmacies; Independent Pharmacies; Online Pharmacies; Clinics; Other Distribution Channels
  • Subsegments:
  • 1) By Oral Contraceptive Pills: Combination Pills; Progestin-Only Pills
  • 2) By Topical Contraceptives: Transdermal Patches; Gel Applications
  • 3) By Injectables: Hormonal Injectables; Non-Hormonal Injectables
  • 4) By Diaphragms: Silicone Diaphragms; Latex Diaphragms
  • 5) By Vaginal Rings: Hormonal Rings; Non-Hormonal Rings
  • 6) By Condoms: Male Condoms; Female Condoms
  • 7) By Contraceptive Sponges: Non-Hormonal Sponges; Hormonal Sponges
  • 8) By Subdermal Implants: Hormonal Implants; Non-Hormonal Implants
  • 9) By Intra-Uterine Devices (IUDs): Hormonal IUDs; Copper IUDs
  • Companies Mentioned: Merck & Co. Inc.; Bayer AG; Church & Dwight Co. Inc.; Cipla Inc.; Reckitt Benckiser Group plc; Agile Therapeutics Inc.; Allergan Ltd.; Aurobindo Pharma Limited; Famy Care Ltd.; Glenmark Pharmaceuticals Limited; HLL Lifecare Limited; Johnson & Johnson; Laboratoire HRA Pharma SAS; Lupin Limited; Mankind Pharma Ltd.; Mayer Laboratories Inc.; Mithra Pharmaceuticals SA; Mylan NV; Okamoto Industries Inc.; Pfizer Inc.; Pregna International Ltd.; Syncom Pharmaceuticals; Teva Pharmaceutical Industries Ltd.; The Population Council; Veru Inc.; Zydus Cadila; Shanghai Dahua Pharmaceutical Co. Ltd.; Sichuan Kangdi Pharmaceutical Co. Ltd.; Beijing Zhengyuan Pharmaceutical Co. Ltd.; Zhejiang Huahai Pharmaceutical Co. Ltd.; Chongqing Pharmaceutical Group Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Contraceptives Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Contraceptives Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Contraceptives Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Contraceptives Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Long-Acting Reversible Contraceptives
    • 4.2.2 Increasing Preference For Non-Hormonal Contraceptive Options
    • 4.2.3 Growing Demand For Female-Controlled Contraceptive Methods
    • 4.2.4 Expansion Of Over-The-Counter And Self-Administered Products
    • 4.2.5 Increasing Focus On Adolescent And Young Adult Contraceptive Awareness

5. Contraceptives Market Analysis Of End Use Industries

  • 5.1 Women Of Reproductive Age
  • 5.2 Adolescents And Young Adults
  • 5.3 Men Using Barrier Contraceptives
  • 5.4 Hospitals And Clinics
  • 5.5 Family Planning And Reproductive Health Centers

6. Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Contraceptives Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Contraceptives Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Contraceptives Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Contraceptives Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Contraceptives Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Contraceptives Market Segmentation

  • 9.1. Global Contraceptives Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
  • 9.2. Global Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
  • 9.3. Global Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels
  • 9.4. Global Contraceptives Market, Sub-Segmentation Of Oral Contraceptive Pills, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Combination Pills, Progestin-Only Pills
  • 9.5. Global Contraceptives Market, Sub-Segmentation Of Topical Contraceptives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transdermal Patches, Gel Applications
  • 9.6. Global Contraceptives Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hormonal Injectables, Non-Hormonal Injectables
  • 9.7. Global Contraceptives Market, Sub-Segmentation Of Diaphragms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Silicone Diaphragms, Latex Diaphragms
  • 9.8. Global Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hormonal Rings, Non-Hormonal Rings
  • 9.9. Global Contraceptives Market, Sub-Segmentation Of Condoms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Male Condoms, Female Condoms
  • 9.10. Global Contraceptives Market, Sub-Segmentation Of Contraceptive Sponges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Hormonal Sponges, Hormonal Sponges
  • 9.11. Global Contraceptives Market, Sub-Segmentation Of Subdermal Implants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hormonal Implants, Non-Hormonal Implants
  • 9.12. Global Contraceptives Market, Sub-Segmentation Of Intra-Uterine Devices (IUDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hormonal IUDs, Copper IUDs

10. Contraceptives Market Regional And Country Analysis

  • 10.1. Global Contraceptives Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Contraceptives Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Contraceptives Market

  • 11.1. Asia-Pacific Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Contraceptives Market

  • 12.1. China Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Contraceptives Market

  • 13.1. India Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Contraceptives Market

  • 14.1. Japan Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Contraceptives Market

  • 15.1. Australia Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Contraceptives Market

  • 16.1. Indonesia Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Contraceptives Market

  • 17.1. South Korea Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Contraceptives Market

  • 18.1. Taiwan Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Contraceptives Market

  • 19.1. South East Asia Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Contraceptives Market

  • 20.1. Western Europe Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Contraceptives Market

  • 21.1. UK Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Contraceptives Market

  • 22.1. Germany Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Contraceptives Market

  • 23.1. France Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Contraceptives Market

  • 24.1. Italy Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Contraceptives Market

  • 25.1. Spain Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Contraceptives Market

  • 26.1. Eastern Europe Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Contraceptives Market

  • 27.1. Russia Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Contraceptives Market

  • 28.1. North America Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Contraceptives Market

  • 29.1. USA Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Contraceptives Market

  • 30.1. Canada Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Contraceptives Market

  • 31.1. South America Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Contraceptives Market

  • 32.1. Brazil Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Contraceptives Market

  • 33.1. Middle East Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Contraceptives Market

  • 34.1. Africa Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Contraceptives Market, Segmentation By Product, Segmentation By Age Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Contraceptives Market Regulatory and Investment Landscape

36. Contraceptives Market Competitive Landscape And Company Profiles

  • 36.1. Contraceptives Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Contraceptives Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Contraceptives Market Company Profiles
    • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis

37. Contraceptives Market Other Major And Innovative Companies

  • Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc.

38. Global Contraceptives Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Contraceptives Market

40. Contraceptives Market High Potential Countries, Segments and Strategies

  • 40.1 Contraceptives Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Contraceptives Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Contraceptives Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제